Apellis Pharmaceuticals, Inc.

APLS

APLS has 14 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 0 purchases and 14 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Jan 22 and filed Jan 23. The most active filer was David O. Watson with 12 filings.

Add to watchlist

Filings, ttm

0 buys · 14 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$3.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jan 22

Filed Jan 23

ADViAverage daily dollar volume

–

not on file

Share price · 12M

$41.03 (+0.0%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $17.8M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

DW David O. Watson General Counsel 12 filings CF Cedric Francois Chief Executive Officer 9 filings AD A. Sinclair Dunlop Director 3 filings TS Timothy Eugene Sullivan Chief Financial Officer 3 filings PD Pascal Deschatelets Chief Scientific Officer 2 filings NN Nur Nicholson Chief Technical Officer 2 filings AT Adam J. Townsend Chief Commercial Officer 1 filing

Recent filings

David O. WatsonSALE General Counsel $171K
7,832 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET Timothy Eugene SullivanSALE Chief Financial Officer $224K
10,287 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET Nur NicholsonSALE Chief Technical Officer $168K
7,725 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $592K
27,192 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET Pascal DeschateletsSALE Chief Scientific Officer $129K
5,928 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $162K
8,182 sh × $19.79
Exec Jan 20
Filed Jan 21 · 5:30 PM ET David O. WatsonSALE General Counsel $128K
5,780 sh × $22.19
Exec Jan 13
Filed Jan 15 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $226K
10,186 sh × $22.19
Exec Jan 13
Filed Jan 15 · 5:30 PM ET David O. WatsonSALE General Counsel $122K
5,000 sh × $24.49
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET David O. WatsonSALE General Counsel $100K
5,000 sh × $20.06
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET Timothy Eugene SullivanSALE Chief Financial Officer $280K
10,000 sh × $28.03
Exec Oct 21 2025
Filed Oct 23 2025 · 5:30 PM ET David O. WatsonSALE General Counsel $126K
5,000 sh × $25.22
Exec Oct 16 2025
Filed Oct 17 2025 · 5:30 PM ET A. Sinclair DunlopSALE Director $738K
31,092 sh × $23.72
Exec Oct 10 2025
Filed Oct 15 2025 · 5:30 PM ET A. Sinclair DunlopSALE Director $702K
31,092 sh × $22.58
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET A. Sinclair DunlopSALE Director $714K
31,092 sh × $22.95
Exec Sep 19 2025
Filed Sep 19 2025 · 5:30 PM ET David O. WatsonSALE General Counsel $122K
5,000 sh × $24.34
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET David O. WatsonSALE General Counsel $523K
20,000 sh × $26.17
Exec Sep 10 2025
Filed Sep 12 2025 · 5:30 PM ET Timothy Eugene SullivanSALE Chief Financial Officer $1.2M
42,729 sh across 2 lots
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $6.4M
225,000 sh across 2 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET David O. WatsonSALE General Counsel $139K
5,000 sh × $27.80
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $399K
19,725 sh × $20.21
Exec Jul 17 2025
Filed Jul 18 2025 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $2.8M
137,465 sh × $20.19
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET David O. WatsonSALE General Counsel $140K
5,569 sh × $25.10
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET Pascal DeschateletsSALE Chief Scientific Officer $120K
3,948 sh × $30.43
Exec Jan 22 2025
Filed Jan 23 2025 · 5:30 PM ET Cedric FrancoisSALE Chief Executive Officer $412K
13,551 sh × $30.43
Exec Jan 22 2025
Filed Jan 23 2025 · 5:30 PM ET